Coverage
-
February 09, 2026
Biotechnology company Alachua Government Services received approval on Monday from a Delaware bankruptcy judge for a $16 million sale to healthcare investment firm OrbiMed Advisors LLC of the royalty rights to a line of monkey cells being used to develop a smallpox vaccine.
2 other articles on this case.
View all »